Covered recipient · General Payments record
EUGENE KOSHKIN
Allopathic & Osteopathic Physicians Anesthesiology Pain Medicine
General Payments · PY2018–2024
$9,787.67
- Reported across 136 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,004.81 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $569.90 | 10 |
| Medtronic, Inc. | $478.63 | 5 |
| Abbott Laboratories | $450.58 | 5 |
| BOSTON SCIENTIFIC CORPORATION | $256.12 | 2 |
| MIMEDX Group, Inc. | $122.29 | 1 |
| SPR Therapeutics, Inc | $95.73 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $124.21 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125091146 | CMS |
| Abbott Laboratories | $9.12 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125091148 | CMS |
| Abbott Laboratories | $108.14 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125091150 | CMS |
| Abbott Laboratories | $70.14 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125091152 | CMS |
| Abbott Laboratories | $138.97 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125091154 | CMS |
| Boston Scientific Corporation | $115.29 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092684263 | CMS |
| Boston Scientific Corporation | $140.83 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092684265 | CMS |
| Medtronic, Inc. | $175.00 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119342256 | CMS |
| Medtronic, Inc. | $122.81 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119342260 | CMS |
| Medtronic, Inc. | $84.57 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119342258 | CMS |
| Medtronic, Inc. | $61.72 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119342262 | CMS |
| Medtronic, Inc. | $34.53 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119342264 | CMS |
| MIMEDX Group, Inc. | $122.29 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140262699 | CMS |
| Nevro Corp. | $139.86 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130747178 | CMS |
| Nevro Corp. | $134.37 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130747208 | CMS |
| Nevro Corp. | $27.16 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130747198 | CMS |
| Nevro Corp. | $129.50 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130747290 | CMS |
| Nevro Corp. | $32.22 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130747292 | CMS |
| Nevro Corp. | $33.63 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130747204 | CMS |
| Nevro Corp. | $13.82 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130747202 | CMS |
| Nevro Corp. | $29.38 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130747210 | CMS |
| Nevro Corp. | $5.80 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130747200 | CMS |
| Nevro Corp. | $24.16 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130747206 | CMS |
| SPR Therapeutics, Inc | $95.73 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104954043 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.56 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137606924 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.